2135 — Raily Aesthetic Medicine International Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Market Cap
HK$80.78m
Enterprise Value
HK$87.78m
Revenue
CNY189.38m

Annual income statement for Raily Aesthetic Medicine International Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	191	165	188	165	189
Cost of Revenue
Gross Profit	101	80.2	69.7	66.8	71.5
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	172	149	205	184	220
Operating Profit	19.1	15.2	-16.9	-19.1	-30.5
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	16.4	11.6	-22.9	-22.1	-35
Provision for Income Taxes
Net Income After Taxes	10.3	4.91	-18.3	-20.2	-37.8
Minority Interest
Net Income Before Extraordinary Items
Net Income	9.9	4.25	-17.7	-15.9	-32.5
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	9.9	4.25	-17.7	-15.9	-32.5
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.041	0.03	-0.036	-0.024	-0.258